Search
Returning search results with filters:
Remove filter for
Category: Biologic or vaccine
Remove filter for
Last updated: 2019
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 7 of 7 items.
Health Canada clarifies position on Platelet Rich Plasma treatments
AlertInformation update | 2019-07-26
Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity
AlertHealth professional risk communication | 2019-05-21
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30
Ventri Nuclear Medicine System and Discovery NM 530c Nuclear Medicine System (2018-12-01)
RecallHealth product recall | 2019-01-08